Variant report
Variant | esv12732 |
---|---|
Chromosome Location | chr8:99935526-99936475 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr8:99935577-99935608 | LNCaP | prostate: | n/a | n/a |
2 | CTCF | chr8:99935500-99935650 | MCF-7 | breast: | n/a | n/a |
3 | FOXA1 | chr8:99936340-99936716 | HepG2 | liver: | n/a | chr8:99936507-99936519 chr8:99936580-99936595 chr8:99936503-99936515 |
4 | FOXA1 | chr8:99936374-99936661 | T-47D | breast: | n/a | chr8:99936507-99936519 chr8:99936580-99936595 chr8:99936503-99936515 |
5 | FOXA1 | chr8:99936291-99936689 | HepG2 | liver: | n/a | chr8:99936507-99936519 chr8:99936580-99936595 chr8:99936503-99936515 |
6 | FOXA1 | chr8:99936260-99936710 | HepG2 | liver: | n/a | chr8:99936507-99936519 chr8:99936580-99936595 chr8:99936503-99936515 |
7 | FOXA1 | chr8:99936282-99936689 | HepG2 | liver: | n/a | chr8:99936507-99936519 chr8:99936580-99936595 chr8:99936503-99936515 |
8 | FOXA2 | chr8:99936337-99936671 | HepG2 | liver: | n/a | chr8:99936507-99936519 chr8:99936503-99936515 |
9 | FOXA2 | chr8:99936205-99936728 | HepG2 | liver: | n/a | chr8:99936507-99936519 chr8:99936503-99936515 |
10 | MXI1 | chr8:99935703-99935711 | Hela-S3 | cervix: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:99935777..99938346-chr8:99942242..99944176,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RN7SKP85 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551360074 | chr8:99935533-99935534 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs527685607 | chr8:99935550-99935551 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs547813457 | chr8:99935606-99935607 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs73279734 | chr8:99935634-99935635 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs375170321 | chr8:99935640-99935641 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs536417829 | chr8:99935678-99935679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs72668449 | chr8:99935699-99935700 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs377162586 | chr8:99935788-99935789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575207409 | chr8:99935799-99935800 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112764141 | chr8:99935814-99935815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191186780 | chr8:99935840-99935841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs144031950 | chr8:99935896-99935897 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537848034 | chr8:99935910-99935911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148756993 | chr8:99935958-99935959 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557468270 | chr8:99935982-99935983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112760558 | chr8:99936024-99936025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs57170067 | chr8:99936080-99936081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149640608 | chr8:99936081-99936082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547875160 | chr8:99936082-99936083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368361300 | chr8:99936083-99936084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2860322 | chr8:99936084-99936085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200703481 | chr8:99936086-99936087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540976874 | chr8:99936088-99936089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554503286 | chr8:99936090-99936091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574118546 | chr8:99936091-99936092 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs3029998 | chr8:99936100-99936101 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543081044 | chr8:99936105-99936106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563079546 | chr8:99936112-99936113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576209869 | chr8:99936118-99936119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540519467 | chr8:99936119-99936120 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571122257 | chr8:99936150-99936151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs17374005 | chr8:99936151-99936152 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs559525468 | chr8:99936181-99936182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573903253 | chr8:99936191-99936192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527943137 | chr8:99936205-99936206 | Weak transcription Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs9801982 | chr8:99936234-99936235 | Weak transcription Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs16897123 | chr8:99936256-99936257 | Weak transcription Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs16897124 | chr8:99936285-99936286 | Weak transcription Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs530130899 | chr8:99936313-99936314 | Weak transcription Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs182202031 | chr8:99936357-99936358 | Weak transcription Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs187688111 | chr8:99936358-99936359 | Weak transcription Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs191113769 | chr8:99936367-99936368 | Weak transcription Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs182826694 | chr8:99936393-99936394 | Weak transcription Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs565740609 | chr8:99936394-99936395 | Weak transcription Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs563009417 | chr8:99936412-99936413 | Weak transcription Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
head and neck squamous cell carcinoma | 19451471 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:99925800-99935800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr8:99927200-99942000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr8:99931800-99936200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
4 | chr8:99932800-99935800 | Weak transcription | Ovary | ovary |
5 | chr8:99933200-99938000 | Weak transcription | Fetal Muscle Leg | muscle |
6 | chr8:99933200-99939000 | Weak transcription | Fetal Muscle Trunk | muscle |
7 | chr8:99934800-99938800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr8:99934800-99938800 | Weak transcription | NHEK | skin |
9 | chr8:99935000-99938800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr8:99935000-99939000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr8:99935600-99939800 | Enhancers | Fetal Lung | lung |
12 | chr8:99935800-99937600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr8:99935800-99939800 | Enhancers | Ovary | ovary |
14 | chr8:99936200-99937000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
15 | chr8:99936200-99937200 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr8:99936400-99939400 | Enhancers | Fetal Stomach | stomach |